ALNYLAM PHARMACEUTICALS INC ($ALNY)

3 tracked superinvestors hold ALNYLAM PHARMACEUTICALS INC (ALNY), worth $1.3B combined, led by Overdeck / Siegel. Smart money is trimming ALNY as of the latest 13F filings.

Current price

$266.11

BiotechnologyNASDAQUS

-41.3%

1Y

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic…

Market cap

$39.5B

P/E

74.59

Div yield

0.0%

Revenue YoY

65.2%

Analyst target

$345

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

3

tracked 13F / N-PORT funds

Combined value

$1.3B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

-1

0 buying · 1 selling

Smart money is net reducing ALNY: 1 funds trimmed versus 0 adding.

The smart-money take on ALNY

ALNYLAM PHARMACEUTICALS INC (ALNY) appears mainly in diversified and quant books here (3 funds, $1.3B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The largest position belongs to Overdeck / Siegel at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.

Superinvestors holding ALNY

InvestorMove% of their portfolioPosition value
2
Trimmed0.4%$565M
3
Steve Wymer

Fidelity Growth Company

Held0.4%$404M
3
Brian Berghuis

T. Rowe Price Mid-Cap Growth

Held1.6%$351M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own ALNY?

3 tracked funds hold ALNYLAM PHARMACEUTICALS INC (ALNY), the largest being Overdeck / Siegel (Two Sigma) at 0.4% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling ALNY?

In the most recent 13F quarter, 0 tracked funds added or opened ALNY and 1 trimmed it.

How much ALNY do tracked funds hold?

Combined disclosed long exposure to ALNY across tracked superinvestors is $1.3B as of the Jun 2026 filings.

Stocks often held alongside ALNY

Get alerted when superinvestors trade $ALNY

One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.